Physician profile
John E Doster
NPI 1982670147
$16,793.02
in general payments reported to CMS, 2019-2025
85 companies · $2,826 in 2025
The $2,826 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,641 · 2020: $1,546 · 2021: $3,143 · 2022: $2,576 · 2023: $2,247 · 2024: $2,813 · 2025: $2,826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,786 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,786.24 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,388.48 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $879.87 | 2019-2025 | Tagrisso, Calquence, Enhertu |
| Janssen Biotech, INC. | $859.98 | 2019-2025 | Darzalex, Tecvayli, Imbruvica |
| Pfizer INC. | $746.29 | 2019-2025 | |
| Gilead Sciences, INC. | $673.50 | 2019-2025 | Trodelvy |
| E.R. Squibb & Sons, L.L.C. | $629.01 | 2019-2025 | Opdualag, Opdivo |
| Exelixis INC. | $603.53 | 2019-2025 | Cabometyx |
| Merck Sharp & Dohme LLC | $598.66 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Celgene Corporation | $594.42 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Amgen INC. | $581.01 | 2019-2024 | Nplate, Vectibix, Xgeva |
| Daiichi Sankyo INC. | $569.00 | 2019-2025 | Enhertu, Datroway, Injectafer |
| Incyte Corporation | $533.03 | 2019-2025 | Monjuvi, Pemazyre, Zynyz |
| Astellas Pharma US INC | $531.03 | 2019-2025 | Padcev, Vyloy, Xtandi |
| Bayer Healthcare Pharmaceuticals INC. | $526.72 | 2019-2025 | |
| Eisai INC. | $522.83 | 2019-2025 |
Show all 85 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $522.67 | 2020-2023 | Padcev, Tukysa |
| Genentech USA, INC. | $459.15 | 2019-2025 | Phesgo, Polivy, Tecentriq |
| Abbvie INC. | $330.18 | 2021-2025 | Lupron Depot, Venclexta |
| Genzyme Corporation | $321.50 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $285.85 | 2019-2025 | Ninlaro, Alunbrig, Fruzaqla |
| Lilly USA, LLC | $268.46 | 2019-2024 | Jaypirca, Retevmo, Verzenio |
| Ipsen Biopharmaceuticals, INC | $220.97 | 2019-2025 | Onivyde, Somatuline Depot, Tazverik |
| Kite Pharma, INC. | $213.82 | 2019-2023 | |
| Jazz Pharmaceuticals INC. | $211.90 | 2020-2025 | Zepzelca |
| Taiho Oncology, INC. | $177.07 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $175.58 | 2019-2024 | Libtayo |
| Coherus Oncology, INC. | $174.99 | 2020-2023 | |
| Glaxosmithkline, LLC. | $167.40 | 2021-2025 | Ojjaara, Zejula, Jemperli |
| Emd Serono, INC. | $136.82 | 2019-2025 | Bavencio |
| Rigel Pharmaceuticals, INC. | $134.99 | 2021-2025 | Rezlidhia, Tavalisse, Gavreto |
| Acrotech Biopharma INC. | $118.05 | 2021-2025 | Beleodaq |
| Adaptive Biotechnologies Corporation | $113.10 | 2022-2024 | Clonoseq |
| Beigene USA, INC. | $113.07 | 2020-2025 | Brukinsa |
| Kyowa Kirin, INC. | $109.35 | 2019-2025 | Poteligeo |
| Pharmacosmos Therapeutics INC. | $108.09 | 2021-2025 | Cosela, Monoferric |
| Alexion Pharmaceuticals, INC. | $100.07 | 2021-2024 | Ultomiris |
| Pharmacyclics LLC, An Abbvie Company | $96.10 | 2019-2022 | |
| Aveo Pharmaceuticals, INC. | $93.65 | 2021-2025 | |
| Global Blood Therapeutics, INC. | $91.85 | 2021-2022 | |
| Karyopharm Therapeutics INC. | $88.06 | 2020-2025 | Xpovio |
| G1 Therapeutics, INC. | $84.44 | 2022-2023 | Cosela |
| Sumitomo Pharma America, INC. | $84.19 | 2023-2024 | Orgovyx |
| Mirati Therapeutics, INC. | $83.21 | 2023-2024 | Krazati |
| Array Biopharma INC | $81.50 | 2019-2025 | Mektovi, Braftovi, Tukysa |
| Blueprint Medicines Corporation | $81.27 | 2021-2024 | Ayvakit |
| Deciphera Pharmaceuticals INC. | $73.45 | 2021-2023 | Qinlock |
| Puma Biotechnology, INC. | $63.60 | 2019-2025 | |
| Springworks Therapeutics, INC. | $62.45 | 2024-2025 | Ogsiveo, Gomekli |
| Beone Medicines USA, INC. | $60.07 | 2025 | Brukinsa |
| Epizyme, INC. | $59.89 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.19 | 2021-2025 | Gilotrif |
| Tersera Therapeutics LLC | $57.58 | 2022-2025 | Xermelo |
| Genmab U.S., INC. | $56.11 | 2024-2025 | Tivdak |
| Pharmaessentia USA Corporation | $55.10 | 2022-2025 | Besremi |
| Adc Therapeutics America, INC. | $52.57 | 2023-2025 | |
| Secura Bio, INC. | $47.36 | 2019-2020 | |
| Myovant Sciences INC. | $41.56 | 2021-2022 | |
| Foundation Medicine, INC. | $40.63 | 2020-2022 | |
| Servier Pharmaceuticals LLC | $37.67 | 2021-2024 | |
| Dova Pharmaceuticals | $34.80 | 2019 | |
| Spectrum Pharmaceuticals INC. | $34.25 | 2023-2025 | Rolvedon |
| Sun Pharmaceutical Industries INC. | $34.15 | 2023 | Odomzo, Yonsa |
| Tactile Systems Technology INC | $29.72 | 2021-2025 | Flexitouch Plus, Nimbl |
| Stemline Therapeutics INC. | $28.71 | 2025 | Orserdu |
| Sobi, INC | $27.62 | 2022-2024 | |
| Clovis Oncology, INC. | $27.46 | 2019-2020 | |
| Organon LLC | $21.85 | 2021 | |
| Accord Healthcare, INC. | $21.42 | 2022 | |
| Advanced Accelerator Applications | $19.97 | 2020 | |
| Geron Corporation | $19.58 | 2025 | Rytelo |
| Heron Therapeutics, INC. | $19.50 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $18.47 | 2020 | |
| Myriad Genetic Laboratories, INC. | $18.42 | 2021 | |
| Recordati_rare_diseases_inc. | $17.89 | 2023 | Sylvant |
| Sandoz INC. | $17.48 | 2021 | |
| Azurity Pharmaceuticals, INC. | $17.09 | 2025 | Danziten |
| Progenics Pharmaceuticals, INC. | $16.97 | 2024 | |
| Novocure INC. | $16.85 | 2022 | |
| Morphosys, US INC. | $16.14 | 2021 | |
| Aurobindo Pharma USA, INC. | $15.94 | 2020 | |
| Alnylam Pharmaceuticals INC. | $15.85 | 2023 | Givlaari |
| Agios Pharmaceuticals, INC. | $15.80 | 2022 | |
| Verastem, INC. | $12.91 | 2019 | |
| Mylan Institutional INC. | $11.97 | 2020 | |
| Amag Pharmaceuticals, INC. | $11.27 | 2019 |
Drugs and devices associated with these payments
Enhertu $441Xofigo $339Nubeqa $339Lenvima $292Darzalex $266Padcev $234Tecvayli $233Reblozyl $221Tukysa $210Xtandi $209Opdualag $207Ibrance $195Imbruvica $191Scemblix $187Cabometyx $186Talzenna $173Keytruda $172Sarclisa $168Orgovyx $164Trodelvy $160Jaypirca $144Venclexta $127Fabhalta $126Verzenio $123Retevmo $123Kisqali $110Opdivo $109Promacta $108Brukinsa $106Talvey $102Monjuvi $97.07Welireg $95.39Inlyta $92.48Cosela $89.63Tagrisso $89.51Erleada $88.99Tavalisse $84.11Rezlidhia $84.11Krazati $83.21Lynparza $81.95Poteligeo $81.60Calquence $77.65Ninlaro $76.80Lutathera $68.20Beleodaq $68.04Rybrevant $66.11Emrelis $60.14Zepzelca $59.76Ojjaara $59.58Pemazyre $58.88Pomalyst $58.75Adcetris $58.07Elrexfio $58.07Tivdak $56.11Onivyde $55.17Bavencio $52.25Vyloy $51.97Mektovi $46.83Zejula $44.87Jemperli $44.87Phesgo $41.90Braftovi $41.86Fotivda $39.78Ayvakit $38.43Zynyz $38.19Zynlonta $38.07Polivy $37.17Tasigna $36.97Xermelo $36.68Ogsiveo $36.41Ultomiris $36.18Besremi $36.11Rolvedon $34.25Odomzo $34.15Somatuline Depot $33.71Jakafi $30.08Bosulif $29.70Alunbrig $29.53Pluvicto $29.36Orserdu $28.71Blenrep $28.41Elahere $27.84Fruzaqla $27.34Datroway $27.25Qinlock $26.96Libtayo $26.60Piqray $26.50Gomekli $26.04Keytruda Qlex $25.75Mekinist $24.05Clonoseq $24.03Lorbrena $23.69Injectafer $22.28Tecentriq $21.79Iclusig $21.65Inqovi $21.34Lonsurf $21.34Gilotrif $20.77Monoferric $20.42Gavreto $20.34
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Doster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.